MARKET NEWS

BrainStorm Announces First Contracted US Clinical Site for Phase 2 Progressive MS Study
Mogrify Raises $3.7 Million to Accelerate Mission to Transform Cell Therapy Via Direct Cellular Conversion
ARCA Biopharma Announces FDA Agreement for a Single Phase 3 Clinical Trial
Saama Partners With The Leukemia & Lymphoma Society & Unveils New Capabilities for Award-Winning Life Science Analytics Cloud
ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial
CytoDyn Files for Orphan Drug Designation for Triple-Negative Breast Cancer

  FEATURED EDITORIAL

  COMPANY PROFILE

Drug Delivery Experts (DDE Labs) is a contract R&D drug delivery laboratory located in San Diego’s emerging biotech sector that specializes in drug product development. We have the expertise to integrate drug delivery formulations with the appropriate device to maximize commercial potential. DDE Labs was created in 2014 to address the gap of good outsourcing partners in the formulation and drug delivery technology landscape. We specialize in drug-device combination product development and integration of formulation and delivery system approaches with commercial strategy and life-cycle plans. We work in the injectable products space as well as alternate delivery systems. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Sapreme Technologies to Develop an Oligonucleotide Delivery Platform

Sapreme Technologies to Develop an Oligonucleotide Delivery Platform

Sapreme Technologies has been awarded a $7.71 million grant together with a multidisciplinary consortium including 11 other academic and industrial parties.

PPD & HLT to Create Data Science-Driven Clinical Research Solutions 

PPD & HLT to Create Data Science-Driven Clinical Research Solutions 

Pharmaceutical Product Development, LLC and Happy Life Tech of China have signed an exclusive agreement to develop a distinctive service offering for the China drug development market delivering data science-driven clinical trials and real-world evidence of drug products’ effectiveness, safety, and value.

Moleculin Announces Out-Licensing Deal to Accelerate Preclinical & Clinical Development

Moleculin Announces Out-Licensing Deal to Accelerate Preclinical & Clinical Development

Moleculin Biotech, Inc. recently announced it has entered into a sub-license agreement with WPD Pharmaceuticals (WPD), located in Poland.

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

March 6 – Transdermal/Topical Delivery
March 13 – Particle Design Technology